CoChat

Characterizing the Clinical Features and Atrophy Patterns of MAPT -Related Frontotemporal Dementia With Disease Progression Modeling

Open access
Young, Alexandra L., Bocchetta, Martina, Russell, Lucy L., Convery, Rhian S., Peakman, Georgia, Todd, Emily, Cash, David M., Greaves, Caroline V., van Swieten, John, Jiskoot, Lize, Seelaar, Harro, Moreno, Fermin, Sanchez-Valle, Raquel, Borroni, Barbara, Laforce, Robert, Masellis, Mario, Tartaglia, Maria Carmela, Graff, Caroline, Galimberti, Daniela, Rowe, James B., Finger, Elizabeth, Synofzik, Matthis, Vandenberghe, Rik, de Mendonça, Alexandre, Tagliavini, Fabrizio, Santana, Isabel, Ducharme, Simon, Butler, Chris, Gerhard, Alex, Levin, Johannes, Danek, Adrian, Otto, Markus, Sorbi, Sandro, Williams, Steven C.R., Alexander, Daniel C., Rohrer, Jonathan D., on behalf of the Genetic FTD Initiative (GENFI), Rossor, Martin N., Fox, Nick C., Warren, Jason D., Woollacott, Ione, Shafei, Rachelle, Heller, Carolin, Swift, Imogen J, Moore, Katrina, Guerreiro, Rita, Bras, Jose, Thomas, David L., Nicholas, Jennifer, Mead, Simon, Meeter, Lieke, Panman, Jessica, Papma, Janne M., Poos, Jackie, van Minkelen, Rick, Pijnenburg, Yolande, Barandiaran, Myriam, Indakoetxea, Begoña, Gabilondo, Alazne, Tainta, Mikel, de Arriba, María, Gorostidi, Ana, Zulaica, Miren, Villanua, Jorge, Díaz, Zigor, Borrego-Ecija, Sergi, Olives, Jaume, Lladó, Albert, Balasa, Mircea, Antonell, Anna, Bargalló, Nuria, Premi, Enrico, Cosseddu, Maura, Gazzina, Stefano, Padovani, Alessandro, Gasparotti, Roberto, Archetti, Silvana, Black, Sandra, Mitchell, Sara, Rogaeva, Ekaterina, Freedman, Morris, Keren, Ron, Tang-Wai, David, Öijerstedt, Linn, Andersson, Christin, Jelic, Vesna, Thonberg, Hakan, Arighi, Andrea, Fenoglio, Chiara, Scarpini, Elio, Fumagalli, Giorgio, Cope, Thomas, Timberlake, Carolyn, Rittman, Timothy, Shoesmith, Christen, Bartha, Robart, Rademakers, Rosa, Wilke, Carlo, Karnath, Hans Otto, Bender, Benjamin, Bruffaerts, Rose, Van Damme, Philip, Vandenbulcke, Mathieu, Ferreira, Catarina B., Miltenberger, Gabriel, Maruta, Carolina, Verdelho, Ana, Afonso, Sónia, Taipa, Ricardo, Caroppo, Paola, Di Fede, Giuseppe, Giaccone, Giorgio, Prioni, Sara, Redaelli, Veronica, Rossi, Giacomina, Tiraboschi, Pietro, Duro, Diana, Almeida, Maria Rosario, Branco, Miguel Castelo, Leitão, Maria João, Pereira, Miguel Tábuas, Santiago, Beatriz, Gauthier, Serge, Neto, Pedro Rosa, Veldsman, Michele, Thompson, Paul, Prix, Catharina, Hoegen, Tobias, Mag.rer.nat, Elisabeth Wlasich, Loosli, Sandra, Schönecker, Sonja, Dr.hum.bio, Elisa Semler, Psych, Dipl., Anderl-Straub, Sarah, Psych, Dipl., Nacmias, Benedetta, Ferrari, Camilla, Polito, Cristina, Lombardi, Gemma, Bessi, Valentina · 2021 · Neurology

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background and Objective Mutations in the MAPT gene cause frontotemporal dementia (FTD). Most previous studies investigating the neuroanatomical signature of MAPT mutations have grouped all different mutations together and shown an association with focal atrophy of the temporal lobe. The variability in atrophy patterns between each particular MAPT mutation is less well-characterized. We aimed to investigate whether there were distinct groups of MAPT mutation carriers based on their neuroanatomical signature. Methods We applied Subtype and Stage Inference (SuStaIn), an unsupervised machine learning technique that identifies groups of individuals with distinct progression patterns, to characterize patterns of regional atrophy in MAPT-associated FTD within the Genetic FTD Initiative (GENFI) cohort study. Results Eighty-two MAPT mutation carriers were analyzed, the majority of whom had P301L, IVS10+16, or R406W mutations, along with 48 healthy noncarriers. SuStaIn identified 2 groups of MAPT mutation carriers with distinct atrophy patterns: a temporal subtype, in which atrophy was most prominent in the hippocampus, amygdala, temporal cortex, and insula; and a frontotemporal subtype, in which atrophy was more localized to the lateral temporal lobe and anterior insula, as well as the orbitofrontal and ventromedial prefrontal cortex and anterior cingulate. There was one-to-one mapping between IVS10+16 and R406W mutations and the temporal subtype and near one-to-one mapping between P301L mutations and the frontotemporal subtype. There were differences in clinical symptoms and neuropsychological test scores between subtypes: the temporal subtype was associated with amnestic symptoms, whereas the frontotemporal subtype was associated with executive dysfunction. Conclusion Our results demonstrate that different MAPT mutations give rise to distinct atrophy patterns and clinical phenotype, providing insights into the underlying disease biology and potential utility for patient stratification in therapeutic trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000012410

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Subtype Progression Patterns Identified by Subtype and Stage Inference (SuStaIn) Each progression pattern consists of a set of stages at which regional brain volumes in MAPT mutation carriers (symptomatic and presymptomatic) reach different z scores relative to noncarriers. (A) Spatial distribution and severity of atrophy at each SuStaIn stage based on the most likely subtype progression patterns predicted by the SuStaIn algorithm. (B) Uncertainty in the SuStaIn subtype progression patterns for each region, where each region is shaded according to the probability a particular z score is reached at a particular SuStaIn stage, ranging from 0 (white) to 1 (red for a z score of 1, magenta for a z score of 2, blue for a z score of 3, and black for a z score of 5). Visualizations in subfigure A were generated using BrainPainter.13 Ant = anterior; Cing = cingulate; DLPFC = dorsolateral prefrontal cortex; FRP = frontal pole; Post = posterior; VMPFC = ventromedial prefrontal cortex.
Figure 1 Subtype Progression Patterns Identified by Subtype and Stage Inference (SuStaIn) Each progression pattern consists of a set of stages at which regional brain volumes in MAPT mutation carriers (symptomatic and presymptomatic) reach different z scores relative to noncarriers. (A) Spatial distribution and severity of atrophy at each SuStaIn stage based on the most likely subtype progression patterns predicted by the SuStaIn algorithm. (B) Uncertainty in the SuStaIn subtype progression patterns for each region, where each region is shaded according to the probability a particular z score is reached at a particular SuStaIn stage, ranging from 0 (white) to 1 (red for a z score of 1, magenta for a z score of 2, blue for a z score of 3, and black for a z score of 5). Visualizations in subfigure A were generated using BrainPainter.13 Ant = anterior; Cing = cingulate; DLPFC = dorsolateral prefrontal cortex; FRP = frontal pole; Post = posterior; VMPFC = ventromedial prefrontal cortex.CC BY · PubMed Central
Figure 2 Stage Progression at Follow-Up Visits Each point represents an individual’s Subtype and Stage Inference (SuStaIn) stage at baseline and follow-up, with the color indicating the time between baseline and follow-up.
Figure 2 Stage Progression at Follow-Up Visits Each point represents an individual’s Subtype and Stage Inference (SuStaIn) stage at baseline and follow-up, with the color indicating the time between baseline and follow-up.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 65

Metadata

Authors
Young, A. L., Bocchetta, M., Russell, L. L., Convery, R. S., Peakman, G., Todd, E., Cash, D. M., Greaves, C. V., van Swieten, J., Jiskoot, L., Seelaar, H., Moreno, F., Sanchez-Valle, R., Borroni, B., Laforce, R., Masellis, M., Tartaglia, M. C., Graff, C., Galimberti, D., Rowe, J. B., Finger, E., Synofzik, M., Vandenberghe, R., de Mendonça, A., Tagliavini, F., Santana, I., Ducharme, S., Butler, C., Gerhard, A., Levin, J., Danek, A., Otto, M., Sorbi, S., Williams, S. C. R., Alexander, D. C., Rohrer, J. D., (GENFI), O. B. O. T. G. F. I., Rossor, M. N., Fox, N. C., Warren, J. D., Woollacott, I., Shafei, R., Heller, C., Swift, I. J., Moore, K., Guerreiro, R., Bras, J., Thomas, D. L., Nicholas, J., Mead, S., Meeter, L., Panman, J., Papma, J. M., Poos, J., van Minkelen, R., Pijnenburg, Y., Barandiaran, M., Indakoetxea, B., Gabilondo, A., Tainta, M., de Arriba, M., Gorostidi, A., Zulaica, M., Villanua, J., Díaz, Z., Borrego-Ecija, S., Olives, J., Lladó, A., Balasa, M., Antonell, A., Bargalló, N., Premi, E., Cosseddu, M., Gazzina, S., Padovani, A., Gasparotti, R., Archetti, S., Black, S., Mitchell, S., Rogaeva, E., Freedman, M., Keren, R., Tang-Wai, D., Öijerstedt, L., Andersson, C., Jelic, V., Thonberg, H., Arighi, A., Fenoglio, C., Scarpini, E., Fumagalli, G., Cope, T., Timberlake, C., Rittman, T., Shoesmith, C., Bartha, R., Rademakers, R., Wilke, C., Karnath, H. O., Bender, B., Bruffaerts, R., Van Damme, P., Vandenbulcke, M., Ferreira, C. B., Miltenberger, G., Maruta, C., Verdelho, A., Afonso, S., Taipa, R., Caroppo, P., Di Fede, G., Giaccone, G., Prioni, S., Redaelli, V., Rossi, G., Tiraboschi, P., Duro, D., Almeida, M. R., Branco, M. C., Leitão, M. J., Pereira, M. T., Santiago, B., Gauthier, S., Neto, P. R., Veldsman, M., Thompson, P., Prix, C., Hoegen, T., Mag.rer.nat, E. W., Loosli, S., Schönecker, S., Dr.hum.bio, E. S., Psych, D., Anderl-Straub, S., Psych, D., Nacmias, B., Ferrari, C., Polito, C., Lombardi, G., & Bessi, V.
Affiliations
  • Western University (CA)
  • King's College London (GB)
  • From the Department of Neuroimaging (A.L.Y., S.C.R.W.), Institute of Psychiatry, Psychology and Neuroscience, King's College London; Departments of Computer Science (A.L.Y., D.C.A.) and Medical Physics and Biomedical Engineering (D.M.C.), Centre for Medical Image Computing, University College London; Dementia Research Centre (M.B., L.L.R., R.S.C., G.P., E.T., D.M.C., C.V.G., L.J., J.D.R.), Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK; Department of...
Corresponding author
Rohrer, Jonathan D.
ORCID
Venue
Neurology
Published
2021-08-31
Volume
97
Issue
9
Pages
e941-e952
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3176508287
Cited by
62
References
18
Citations by year
2026: 10 · 2025: 14 · 2024: 11 · 2023: 16 · 2022: 9 · 2021: 2
FWCI
6.82
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Brunel University Research Archive (BURA) (Brunel University London) (submittedVersion, cc-by)
  • Florence Research (University of Florence) (submittedVersion, other-oa)
  • Iris (University of Trento) (submittedVersion, cc-by)
  • Lirias (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion, cc-by)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • DZNE Pub (submittedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
  • Apollo
Funders
  • Association for Frontotemporal Degeneration
  • Eli Lilly and Company
  • Biogen
  • Wellcome Trust (103838/Z/14/Z, 103838)
  • EU Joint Programme – Neurodegenerative Disease Research
  • Brain Research UK (202021-32)
  • Astex Pharmaceuticals
  • Alzheimer's Society (AS‐PG‐16‐007)
  • National Institute for Health and Care Research (BRC149/NS/MH)
  • Brain Research Trust
  • Guarantors of Brain
  • European Commission
  • Wolfson Foundation
  • Deutsche Forschungsgemeinschaft
  • Cambridge University Hospitals (146281)
  • Ministero della Salute
  • UK Dementia Research Institute
  • Canadian Institutes of Health Research
  • Medical Research Council (MR/T027800/1, MR/M023664/1, MR/T046015/1, MR/M008525/1, MR/K010395/1)
  • Menzies Centre for Australian Studies, King's College London, University of London
  • NIHR Cambridge Biomedical Research Centre (BRC149/NS/MH)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
frontotemporal dementia, MAPT mutations, tauopathy, regional brain atrophy, P301L mutation, disease progression modeling, SuStaIn, temporal lobe atrophy, executive dysfunction, patient stratification
MeSH terms
Machine Learning, Adult, Aged, Atrophy, Brain, Female, Humans, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Mutation, tau Proteins, Disease Progression, Frontotemporal Dementia, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterizing the Clinical Features and Atrophy Patterns of MAPT -Related Frontotemporal Dementia With Disease Progression Modeling. https://app.cochat.ai/papers/10.1212/wnl.0000000000012410
The paper
Young, A. L., Bocchetta, M., Russell, L. L., Convery, R. S., Peakman, G., Todd, E., Cash, D. M., Greaves, C. V., van Swieten, J., Jiskoot, L., Seelaar, H., Moreno, F., Sanchez-Valle, R., Borroni, B., Laforce, R., Masellis, M., Tartaglia, M. C., Graff, C., Galimberti, D., . . . Bessi, V. (2021). Characterizing the Clinical Features and Atrophy Patterns of MAPT -Related Frontotemporal Dementia With Disease Progression Modeling. Neurology. https://doi.org/10.1212/wnl.0000000000012410

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.